Mission: The mission of Regional Health Clinical Research (RHCR) is to support innovative clinical research and provide quality clinical research services to the physicians and citizens of our local communities.
Clinical research is an essential key to healthcare. Patient volunteers help doctors and scientists discover opportunities to improve patient care, advance treatments, diagnostics, medications and devices.
Trials: The Clinical Research Department, a department of Regional Health, participates in multiple research studies providing research coordination and study management services for physicians conducting clinical research studies. Regional Health Research Clinical Research incorporates over 43 providers (Insert Link to Researchers bio box #5) representing more than 16 specialty areas:
- Radiation Oncology
- Medical Oncology
- Gynecological Oncology
- Cardiac Electrophysiology
- Interventional Cardiology
- Vascular Medicine
- Nuclear Cardiology
- Endovascular Medicine
- Family Medicine
- Pediatric Medicine
- Pediatric Endocrinology
- Infectious Disease
Learn More About Clinical Studies (Insert link to https://clinicaltrials.gov/ct2/about-studies/learn)
The types of studies conducted at Regional Health Research include:
- Treatment studies to improve the standard of care
- Prevention studies to look for better ways to prevent disease
- Diagnostic and screening studies designed to find better ways to detect diseases
- Pharmaceutical trials to advance medical treatment
- Cardiac device trials
- Symptom management trials to treat and reduce side effects from cancer treatments
Clinical research trials are conducted in phases, or steps to answer multiple research questions. According to www.nlm.nih.gov/services/ctphases.html, phases are individually defined as:
Phase I: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase II: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase III: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug’s effect in various populations and any side effects associated with long-term use.
Regional Health Institutional Review Board
PO Box 6000
Rapid City, SD 57709-6000
Phone: (605) 755-9037
Regional Health Clinical Research
Contact: Crystal Gruetzmacher
Phone: (605) 755-3982
Cancer Care Institute Research
Contact: Angie Dunbar
Clinical Research FAQs